Meggy Suarez‐Carmona
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 2
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Microbiology top 5%
- Modeling and Simulation top 5%
-
- Cervical Cancer and HPV Research 3
-
- Colorectal and Anal Carcinomas 3
-
- Fibroblast Growth Factor Research 2
- Co-authors
- Christine GillesJulien LesageDidier CataldoPascale HubertPhilippe DelvenneMichaël HerfsNiels HalamaJakob Nikolas Kather
- Cited by
- OncologyCancer ResearchImmunology
In The Last Decade
Meggy Suarez‐Carmona
22 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 624
- Cancer Research 331
- Immunology 396
- Microbiology 77
- Modeling and Simulation 55
Countries citing papers authored by Meggy Suarez‐Carmona
This map shows the geographic impact of Meggy Suarez‐Carmona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meggy Suarez‐Carmona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meggy Suarez‐Carmona more than expected).
Fields of papers citing papers by Meggy Suarez‐Carmona
This network shows the impact of papers produced by Meggy Suarez‐Carmona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meggy Suarez‐Carmona. The network helps show where Meggy Suarez‐Carmona may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meggy Suarez‐Carmona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 57 | |
| 3 | 2020 | 8 | |
| 4 | 2018 | 33 | |
| 5 | 2018 | 1 | |
| 6 | 2017 | 79 | |
| 7 | 2017 | 30 | |
| 8 | 2017 | 22 | |
| 9 | EMT and inflammation: inseparable actors of cancer progressionbreakdown → | 2017 | 440 |
| 10 | 2016 | 82 | |
| 11 | Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells | 2016 | 4 |
| 12 | 2016 | 2 | |
| 13 | 2016 | 26 | |
| 14 | 2015 | 26 | |
| 15 | 2015 | 50 | |
| 16 | 2015 | 50 | |
| 17 | 2014 | 91 | |
| 18 | 2014 | 16 | |
| 19 | 2014 | 24 | |
| 20 | 2010 | 38 |
About Meggy Suarez‐Carmona
Meggy Suarez‐Carmona is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (4 papers), Cervical Cancer and HPV Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Colorectal and Anal Carcinomas (3 papers), Fibroblast Growth Factor Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (624 citations), Cancer Research (331 citations) and Immunology (396 citations). Meggy Suarez‐Carmona has collaborated with scholars based in Belgium, Germany and France. Frequent co-authors include Christine Gilles, Julien Lesage, Didier Cataldo, Pascale Hubert, Philippe Delvenne, Michaël Herfs, Niels Halama, Jakob Nikolas Kather, Esther Herpel and Pornpimol Charoentong. Their work appears in journals such as The Journal of Pathology, Cancer Research, Molecular Oncology, Oral Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.